TY - JOUR T1 - New topical drugs for open-angle glaucoma JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 12 LP - 14 DO - 10.1136/dtb.2003.41212 VL - 41 IS - 2 A2 - , Y1 - 2003/02/01 UR - http://dtb.bmj.com/content/41/2/12.abstract N2 - Relevant BNF section: 11.6When we reviewed the management of open-angle glaucoma in 1997,1 the topical drug treatments available included beta-blockers, a carbonic anhydrase inhibitor (dorzolamide), an alpha2 agonist (apraclonidine), a prostaglandin analogue (latanoprost) and a variety of miotics and sympathomimetics. We concluded that a beta-blocker was the treatment of first choice. Here, we review seven new topical preparations that have been marketed, or had their licensed indications changed, since our earlier article. ER -